RU2013120927A - Аналоги циклоспорина - Google Patents
Аналоги циклоспорина Download PDFInfo
- Publication number
- RU2013120927A RU2013120927A RU2013120927/04A RU2013120927A RU2013120927A RU 2013120927 A RU2013120927 A RU 2013120927A RU 2013120927/04 A RU2013120927/04 A RU 2013120927/04A RU 2013120927 A RU2013120927 A RU 2013120927A RU 2013120927 A RU2013120927 A RU 2013120927A
- Authority
- RU
- Russia
- Prior art keywords
- compound according
- chch
- isobutyl
- alkyl
- compound
- Prior art date
Links
- PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical class CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 title claims abstract 7
- 150000001875 compounds Chemical class 0.000 claims abstract 24
- GVNVAWHJIKLAGL-UHFFFAOYSA-N 2-(cyclohexen-1-yl)cyclohexan-1-one Chemical compound O=C1CCCCC1C1=CCCCC1 GVNVAWHJIKLAGL-UHFFFAOYSA-N 0.000 claims abstract 12
- 101150065749 Churc1 gene Proteins 0.000 claims abstract 12
- 102100038239 Protein Churchill Human genes 0.000 claims abstract 12
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 claims abstract 11
- -1 2-hydroxyisobutyl Chemical group 0.000 claims abstract 9
- 229930105110 Cyclosporin A Natural products 0.000 claims abstract 6
- 108010036949 Cyclosporine Proteins 0.000 claims abstract 6
- 229960001265 ciclosporin Drugs 0.000 claims abstract 6
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims abstract 4
- 125000004066 1-hydroxyethyl group Chemical group [H]OC([H])([*])C([H])([H])[H] 0.000 claims abstract 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims abstract 4
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims abstract 4
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 claims abstract 4
- 229910052757 nitrogen Inorganic materials 0.000 claims abstract 4
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims abstract 4
- 125000000217 alkyl group Chemical group 0.000 claims abstract 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims abstract 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims abstract 2
- 125000003709 fluoroalkyl group Chemical group 0.000 claims abstract 2
- 125000005842 heteroatom Chemical group 0.000 claims abstract 2
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims abstract 2
- 125000004433 nitrogen atom Chemical group N* 0.000 claims abstract 2
- 239000001301 oxygen Substances 0.000 claims abstract 2
- 229910052760 oxygen Inorganic materials 0.000 claims abstract 2
- 150000003839 salts Chemical class 0.000 claims abstract 2
- 229920006395 saturated elastomer Polymers 0.000 claims abstract 2
- 206010023332 keratitis Diseases 0.000 claims 3
- 238000000034 method Methods 0.000 claims 3
- 241000124008 Mammalia Species 0.000 claims 2
- 210000004087 cornea Anatomy 0.000 claims 2
- 201000010666 keratoconjunctivitis Diseases 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims 2
- 206010003645 Atopy Diseases 0.000 claims 1
- 208000009137 Behcet syndrome Diseases 0.000 claims 1
- 208000009299 Benign Mucous Membrane Pemphigoid Diseases 0.000 claims 1
- 206010010744 Conjunctivitis allergic Diseases 0.000 claims 1
- 208000003556 Dry Eye Syndromes Diseases 0.000 claims 1
- 206010013774 Dry eye Diseases 0.000 claims 1
- 208000009329 Graft vs Host Disease Diseases 0.000 claims 1
- 208000009889 Herpes Simplex Diseases 0.000 claims 1
- 206010072139 Ocular rosacea Diseases 0.000 claims 1
- 201000002154 Pterygium Diseases 0.000 claims 1
- 208000036142 Viral infection Diseases 0.000 claims 1
- 208000016807 X-linked intellectual disability-macrocephaly-macroorchidism syndrome Diseases 0.000 claims 1
- 208000002205 allergic conjunctivitis Diseases 0.000 claims 1
- 208000024998 atopic conjunctivitis Diseases 0.000 claims 1
- 206010069664 atopic keratoconjunctivitis Diseases 0.000 claims 1
- 208000010217 blepharitis Diseases 0.000 claims 1
- 208000037976 chronic inflammation Diseases 0.000 claims 1
- 230000006020 chronic inflammation Effects 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 206010015907 eye allergy Diseases 0.000 claims 1
- 208000027993 eye symptom Diseases 0.000 claims 1
- 208000024908 graft versus host disease Diseases 0.000 claims 1
- 230000001771 impaired effect Effects 0.000 claims 1
- 210000004175 meibomian gland Anatomy 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 208000015200 ocular cicatricial pemphigoid Diseases 0.000 claims 1
- 201000004700 rosacea Diseases 0.000 claims 1
- 230000035945 sensitivity Effects 0.000 claims 1
- 238000001356 surgical procedure Methods 0.000 claims 1
- 230000009385 viral infection Effects 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
- C07K7/645—Cyclosporins; Related peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Ophthalmology & Optometry (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Transplantation (AREA)
- Biotechnology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US39245110P | 2010-10-12 | 2010-10-12 | |
| US61/392,451 | 2010-10-12 | ||
| PCT/US2011/055788 WO2012051193A1 (en) | 2010-10-12 | 2011-10-11 | Cyclosporin analogs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2013120927A true RU2013120927A (ru) | 2014-11-20 |
Family
ID=44883796
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2013120927/04A RU2013120927A (ru) | 2010-10-12 | 2011-10-11 | Аналоги циклоспорина |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US9175042B2 (enExample) |
| EP (1) | EP2627663B1 (enExample) |
| JP (1) | JP5805773B2 (enExample) |
| KR (1) | KR20140026328A (enExample) |
| CN (1) | CN103261212A (enExample) |
| AU (1) | AU2011316689B2 (enExample) |
| BR (1) | BR112013008749A2 (enExample) |
| CA (1) | CA2814191A1 (enExample) |
| IL (1) | IL225616A0 (enExample) |
| MX (1) | MX2013004062A (enExample) |
| RU (1) | RU2013120927A (enExample) |
| WO (1) | WO2012051193A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100305047A1 (en) * | 2009-05-27 | 2010-12-02 | Allergan, Inc. | Cyclosporin derivatives for enhancing the growth of hair |
| PL2651965T3 (pl) * | 2010-12-15 | 2019-04-30 | Contravir Pharmaceuticals Inc | Cząsteczki analogów cyklosporyny modyfikowane w aminokwasach 1 i 3 |
| AU2013267435B2 (en) | 2012-06-01 | 2017-11-09 | Allergan, Inc. | Cyclosporin A analogs |
| WO2014138437A1 (en) | 2013-03-08 | 2014-09-12 | Allergan, Inc. | Steroid conjugates |
| WO2016112321A1 (en) | 2015-01-08 | 2016-07-14 | Allergan, Inc. | Cyclosporin derivatives wherein the mebmt sidechain has been cyclized |
| EP3551047A1 (en) | 2016-12-07 | 2019-10-16 | Progenity, Inc. | Gastrointestinal tract detection methods, devices and systems |
| CA3046023A1 (en) | 2016-12-14 | 2018-06-21 | Progenity, Inc. | Treatment of a disease of the gastrointestinal tract with an immunosuppressant |
| US20230041197A1 (en) | 2018-06-20 | 2023-02-09 | Progenity, Inc. | Treatment of a disease of the gastrointestinal tract with an immunomodulator |
| CN115028681B (zh) * | 2022-08-11 | 2022-11-15 | 中国科学院微生物研究所 | 一种降解亲环素a的嵌合体化合物及其制备方法与应用 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4649047A (en) | 1985-03-19 | 1987-03-10 | University Of Georgia Research Foundation, Inc. | Ophthalmic treatment by topical administration of cyclosporin |
| US5474979A (en) | 1994-05-17 | 1995-12-12 | Allergan, Inc. | Nonirritating emulsions for sensitive tissue |
| FR2757522B1 (fr) * | 1996-12-24 | 1999-01-29 | Rhone Poulenc Rorer Sa | Derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent |
| FR2757521B1 (fr) * | 1996-12-24 | 1999-01-29 | Rhone Poulenc Rorer Sa | Nouveaux derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent |
| FR2762843B1 (fr) | 1997-04-30 | 1999-12-10 | Rhone Poulenc Rorer Sa | Nouveaux derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent |
| FR2772768B1 (fr) * | 1997-12-19 | 2000-01-14 | Rhone Poulenc Rorer Sa | Nouveau procede de preparation de derives de cyclosporine |
| CA2334730C (en) | 1998-06-12 | 2009-09-29 | C-Chem Ag | Novel cyclosporins |
| US6254860B1 (en) * | 1999-04-13 | 2001-07-03 | Allergan Sales, Inc. | Ocular treatment using cyclosporin-A derivatives |
| CN100478025C (zh) * | 2005-03-25 | 2009-04-15 | 中国科学院上海药物研究所 | 一种环孢菌素a眼用微乳制剂及其制备方法 |
| CA2652662C (en) * | 2006-05-19 | 2015-11-03 | Scynexis, Inc. | Methods for the treatment and prevention of ocular disorders |
| BRPI0811538A2 (pt) | 2007-05-04 | 2015-08-11 | Allergan Inc | Uso de ciclosporinas no tratamento de pacientes com lentes intraoculares. |
| JP5661035B2 (ja) | 2008-07-10 | 2015-01-28 | アラーガン、インコーポレイテッドＡｌｌｅｒｇａｎ，Ｉｎｃｏｒｐｏｒａｔｅｄ | 眼および皮膚の疾患および症状の治療用のシクロスポリン誘導体 |
| CN103153329A (zh) * | 2010-07-16 | 2013-06-12 | 美国科技环球有限公司 | 新颖的环孢霉素a衍生物在病毒感染的治疗和预防中的应用 |
| WO2012021796A2 (en) * | 2010-08-12 | 2012-02-16 | S&T Global, Inc. | Novel cyclosporin derivatives for the treatment and prevention of a viral infection |
| BR112013008864A2 (pt) | 2010-10-12 | 2016-06-28 | Allergan Inc | análogos d ciclosporina |
| AU2011336266B2 (en) | 2010-12-03 | 2017-04-06 | S&T Global Inc. | Novel cyclosporin derivatives for the treatment and prevention of a viral infection |
| US9890198B2 (en) | 2010-12-03 | 2018-02-13 | S&T Global Inc. | Cyclosporin derivatives and uses thereof |
-
2011
- 2011-10-11 US US13/270,929 patent/US9175042B2/en active Active
- 2011-10-11 CA CA2814191A patent/CA2814191A1/en not_active Abandoned
- 2011-10-11 AU AU2011316689A patent/AU2011316689B2/en not_active Ceased
- 2011-10-11 EP EP11770984.0A patent/EP2627663B1/en not_active Not-in-force
- 2011-10-11 CN CN201180059696XA patent/CN103261212A/zh active Pending
- 2011-10-11 KR KR1020137012144A patent/KR20140026328A/ko not_active Withdrawn
- 2011-10-11 RU RU2013120927/04A patent/RU2013120927A/ru not_active Application Discontinuation
- 2011-10-11 WO PCT/US2011/055788 patent/WO2012051193A1/en not_active Ceased
- 2011-10-11 BR BR112013008749A patent/BR112013008749A2/pt not_active IP Right Cessation
- 2011-10-11 MX MX2013004062A patent/MX2013004062A/es unknown
- 2011-10-11 JP JP2013533941A patent/JP5805773B2/ja not_active Expired - Fee Related
-
2013
- 2013-04-07 IL IL225616A patent/IL225616A0/en unknown
-
2015
- 2015-10-02 US US14/873,908 patent/US9561259B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP5805773B2 (ja) | 2015-11-10 |
| MX2013004062A (es) | 2013-07-22 |
| US20160022765A1 (en) | 2016-01-28 |
| AU2011316689B2 (en) | 2016-07-14 |
| EP2627663A1 (en) | 2013-08-21 |
| EP2627663B1 (en) | 2018-02-21 |
| US9175042B2 (en) | 2015-11-03 |
| US20120135939A1 (en) | 2012-05-31 |
| CA2814191A1 (en) | 2012-04-19 |
| KR20140026328A (ko) | 2014-03-05 |
| WO2012051193A1 (en) | 2012-04-19 |
| CN103261212A (zh) | 2013-08-21 |
| BR112013008749A2 (pt) | 2019-09-24 |
| US9561259B2 (en) | 2017-02-07 |
| JP2013544786A (ja) | 2013-12-19 |
| AU2011316689A1 (en) | 2013-05-02 |
| IL225616A0 (en) | 2013-06-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2013120927A (ru) | Аналоги циклоспорина | |
| JP2013544786A5 (enExample) | ||
| RU2013119869A (ru) | Аналоги циклоспорина | |
| ES2993034T3 (en) | Prodrugs of fused-bicyclic c5ar antagonists | |
| ES2668300T3 (es) | Inhibidores de SSAO de 3-haloamidina sustituida y usos de los mismos | |
| AR087301A1 (es) | Derivados de carboxamida y urea que contienen pirazol heteroaromatico sustituido como ligandos del receptor de vanilloide | |
| RU2011136250A (ru) | Низкомолекулярное полисульфатированное производное гиалуроновой кислоты и содержащее его лекарственное средство | |
| EA201001595A1 (ru) | Соединения и композиции в качестве модуляторов активности gpr119 | |
| JP2013540776A5 (enExample) | ||
| RU2011117927A (ru) | Карбаматное соединение или его соль | |
| TW201444860A (zh) | 脲嘧啶核苷衍生物、組合物及使用方法 | |
| KR20210105916A (ko) | 우루소데옥시콜산을 함유하는 노시의 치료 또는 예방제 | |
| RU2468793C2 (ru) | Композиции на основе соединений 2-амино-1,3-пропандиола | |
| MX2023013683A (es) | Compuestos de isoxazolilo fusionados como inhibidores de lisina acetiltransferasa 6a (kat6a). | |
| EP4330231A1 (en) | 2-methylene-4-oxo-butanoic acid drivatives for the treatment of inflammation | |
| RU2011147186A (ru) | 2, 5-дизамещенные арилсульфонамидные антагонисты ссr3 | |
| RU2013113300A (ru) | Замещенные 2-окси-хинолин-3-карбоксамиды в качестве модуляторов kcnq2/3 | |
| RU2009128968A (ru) | Производные изосорбидмононитрата для лечения повышенной внутриглазной гипертензии | |
| RU2007107935A (ru) | Полисульфатированные гликозиды и их соли | |
| ES3002189T3 (en) | Para-hydroquinone derivatives as vegf, tnf and/or il inhibitors for the treatment of neuroinflammatory diseases | |
| RU2008152751A (ru) | Соли тримебутина и n-десметилтримебутина | |
| JP2013531051A5 (enExample) | ||
| RU2015156196A (ru) | Антифиброгенные соединения, способы и их применение | |
| RU2019109570A (ru) | 8-(азетидин-1-ил)-[1,2,4]триазоло[1,5-а]пиридинилы, композиции и способы их применения | |
| JP6509244B2 (ja) | 水晶体硬化抑制剤 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA93 | Acknowledgement of application withdrawn (no request for examination) |
Effective date: 20141013 |